Fully vaccinated against COVID-19 with a series of two doses that reduce a person’s risk of experiencing long-term symptoms in the “unlikely” event of taking coronavirus, according to a new study.
The study, published this week in the journal Lancet Disease, examined more than 1 million adults in the UK and found that full vaccination with rifles from Pfizer, Moderna or AstraZeneca reduces the risk of long-term COVID ”By 49%.
“In terms of Long COVID load, it is good news that our research has found that having a double dose of vaccine significantly reduces the risk of taking both protein and if it does, develop long-term symptoms,” Claire Steves, a physiotherapist at King’s College London and the lead author of the study, said in a statement. “However, among our weaknesses, older adults and those living in high-risk areas are also important and should be prioritized for secondary immunizations and promotion.”
The study authors suggest “strategies such as time management, targeted infection control measures and further investigation into the immune response in this group may help address the issue,” according to a statement.
While little is known about “long-term COVID,” symptoms can include fatigue, brain fog, heart failure and other complications.
Of the nearly 1 million people the study examined who had both guns, 0.2% reported stroke infections. The study also found that those who were fully vaccinated but ill were less likely to need hospitalization or face stronger COVID-19 symptoms than those who were not vaccinated.
The authors of the study acknowledge that the study had limitations, including that the data was self-reported by an application.